Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1)
about
sameAs
CX3CL1 is up-regulated in the rat hippocampus during memory-associated synaptic plasticityTumor necrosis factor-alpha-converting enzyme controls surface expression of c-Kit and survival of embryonic stem cell-derived mast cellsAn oxidized lipid-peroxisome proliferator-activated receptor gamma-chemokine pathway in the regulation of macrophage-vascular smooth muscle cell adhesionCellular cholesterol depletion triggers shedding of the human interleukin-6 receptor by ADAM10 and ADAM17 (TACE)Integrin alpha5beta1 and ADAM-17 interact in vitro and co-localize in migrating HeLa cellsAcidic mammalian chitinase is secreted via an ADAM17/epidermal growth factor receptor-dependent pathway and stimulates chemokine production by pulmonary epithelial cellsEngineering N-terminal domain of tissue inhibitor of metalloproteinase (TIMP)-3 to be a better inhibitor against tumour necrosis factor-alpha-converting enzymeOsteoarthritis joint pain: the cytokine connectionMicroglia centered pathogenesis in ALS: insights in cell interconnectivityHeterogeneity of lung mononuclear phagocytes in chronic obstructive pulmonary diseaseRegulation of Chemokine Activity - A Focus on the Role of Dipeptidyl Peptidase IV/CD26Integrins αvβ3 and α4β1 act as coreceptors for fractalkine, and the integrin-binding defective mutant of fractalkine is an antagonist of CX3CR1Greater fractalkine expression in mesenteric arteries of female spontaneously hypertensive rats compared with malesFractalkine and CX 3 CR1 regulate hippocampal neurogenesis in adult and aged ratsTransmembrane chemokines act as receptors in a novel mechanism termed inverse signalingThe spectrum of resistance in SR/CR mice: the critical role of chemoattraction in the cancer/leukocyte interactionDo not let death do us part: 'find-me' signals in communication between dying cells and the phagocytes.Analysis of the Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Traumatic Brain and Spinal Cord Injury: Insight into Recent Advances in Actions of Neurochemokine Agents.Cytoskeletal confinement of CX3CL1 limits its susceptibility to proteolytic cleavage by ADAM10The chemokine fractalkine can activate integrins without CX3CR1 through direct binding to a ligand-binding site distinct from the classical RGD-binding site.Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic root.Circulating fractalkine levels predict the development of the metabolic syndrome.Tumor Therapy Applying Membrane-bound Form of Cytokines.SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.ADAM17 deletion in thymic epithelial cells alters aire expression without affecting T cell developmental progressionADAM-17: the enzyme that does it all.Interactions between chemokines: regulation of fractalkine/CX3CL1 homeostasis by SDF/CXCL12 in cortical neurons.Identification of the chemokine CX3CL1 as a new regulator of malignant cell proliferation in epithelial ovarian cancer.Neurobiology of microglial action in CNS injuries: receptor-mediated signaling mechanisms and functional rolesCloning and expression of ADAM-related metalloproteases in equine laminitisInvolvement of fractalkine/CX3CL1 expression by dendritic cells in the enhancement of host immunity against Legionella pneumophila.CX3CL1 (fractalkine) protein expression in normal and degenerating mouse retina: in vivo studies.Opposing effects of membrane-anchored CX3CL1 on amyloid and tau pathologies via the p38 MAPK pathwayCX3CL1-CX3CR1 interaction prevents carbon tetrachloride-induced liver inflammation and fibrosis in mice.Role of fractalkine/CX3CR1 interaction in light-induced photoreceptor degeneration through regulating retinal microglial activation and migrationADAM10 mediates ectodomain shedding of the betacellulin precursor activated by p-aminophenylmercuric acetate and extracellular calcium influx.Fractalkine (CX3CL1), a new factor protecting β-cells against TNFαFractalkine/CX3CL1: a potential new target for inflammatory diseasesFractalkine promotes human monocyte survival via a reduction in oxidative stressThe impact of MFG-E8 in chronic pancreatitis: potential for future immunotherapy?
P2860
Q21129473-FA02EC89-8DBE-4508-9C9C-8FF6B73DD7B6Q24300017-28F9F138-735D-486F-A839-48F82294A4A7Q24300694-2F5534C0-6300-42F1-961A-A0EF06910360Q24306455-EF3BA4BB-4F4F-40B6-8C44-006954B2F078Q24309589-66BDB236-3151-4763-BFC9-7EE2A9CEAEF3Q24317214-02AA48C1-1D99-4EE8-981B-AB28F717B395Q24534110-7FEC4FEB-E9BC-4AA2-A414-9976C33E5D4BQ26859004-BDDBD3B6-22B7-42CD-9D67-5CF323BFB995Q27009559-8C135A84-E084-4269-B7C9-F0EAF9D1B98DQ27014453-095F6EF3-B3EA-4F70-B6AD-3E3B64A7F7CFQ28072580-8B2ECC95-F8EA-4209-935D-15E32B12B577Q28119172-16DE1276-671F-4A30-ADF9-7DE775536680Q28571899-0A7C784B-8222-4286-9B19-D665EC1920DCQ28576101-A8BEAAE2-F272-4CF1-8147-008E776C9F3FQ28601403-528FC427-BE42-4318-86F5-008EB75890B2Q28972215-91FA0B1B-FAC4-49DF-861D-857F0137BA28Q30277318-42EC362A-5115-45C6-B91E-3E241A179C4AQ30360306-EC4D1DC0-5DC9-4A58-825D-3462C06B2BD9Q30601949-9BEAB5B8-DD22-4309-8AD4-74782CA09138Q31160040-71D34944-9353-4825-A419-ECD6B8F6B1A8Q33580505-5B509684-D8B2-4972-A6B3-6659719F14F8Q33614646-741036EC-80A0-4B5D-B08E-FF2445B1DC19Q33631960-2F015585-DAAB-4923-BEE2-C6128E3D8410Q33645235-806357CA-50A5-4946-A841-B20C198474B7Q33728091-A0AA1FDC-DE8F-4078-8F3A-82664F72D301Q33737421-7D053E76-2910-421A-B0D3-D7C3F636A17FQ33796131-9C27B09F-8D36-4445-B3C6-C31C1CCB4937Q33959320-BFCA95A6-C118-4807-9445-E84EC71DF584Q34002086-5E4B6BAE-8B76-4D5A-B409-36B0FE61FF38Q34009507-9C5FC31E-B452-4A1F-9596-356A4D04D66BQ34033832-D7D733F9-9A7A-415A-A397-A7CC7A038741Q34142149-15DFA135-15AE-4300-B035-70AE534EDC4DQ34162803-4B989594-9F44-44DC-9E5E-0AD8B705DCD1Q34163933-F6D91C57-97AD-4DF2-A256-3986775FE634Q34247267-0B8CA824-EF2C-4B45-8DCB-B67B257C61E3Q34362287-DC81F735-4CDA-43B4-8D46-AFFDADB807C7Q34404086-FD3E143E-1E27-4038-9462-67F5DDEFADA4Q34407627-71A1D4A5-DF9A-4580-BD34-B7F2BA431C28Q34536235-8BBDB09B-C3A2-4AE5-8EC7-D87D9684FD0CQ34550041-E8760AD8-42CF-4AC0-81E5-29D56C94D619
P2860
Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1)
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Tumor necrosis factor-alpha-co ...... edding of fractalkine (CX3CL1)
@ast
Tumor necrosis factor-alpha-co ...... edding of fractalkine (CX3CL1)
@en
Tumor necrosis factor-alpha-co ...... edding of fractalkine (CX3CL1)
@nl
type
label
Tumor necrosis factor-alpha-co ...... edding of fractalkine (CX3CL1)
@ast
Tumor necrosis factor-alpha-co ...... edding of fractalkine (CX3CL1)
@en
Tumor necrosis factor-alpha-co ...... edding of fractalkine (CX3CL1)
@nl
prefLabel
Tumor necrosis factor-alpha-co ...... edding of fractalkine (CX3CL1)
@ast
Tumor necrosis factor-alpha-co ...... edding of fractalkine (CX3CL1)
@en
Tumor necrosis factor-alpha-co ...... edding of fractalkine (CX3CL1)
@nl
P2093
P3181
P356
P1476
Tumor necrosis factor-alpha-co ...... edding of fractalkine (CX3CL1)
@en
P2093
C P Blobel
D R Greaves
E W Raines
K J Garton
P J Dempsey
P304
37993-8001
P3181
P356
10.1074/JBC.M106434200
P407
P577
2001-10-12T00:00:00Z